Inorganic Chemistry
ARTICLE
NMR (500 MHz, CD2Cl2): δ 1.91 (s, 15H, Cp*), 2.00 (s, 15H, Cp*),
2.177 (s, 3H, SO2C6H4-4-CH3), 2.18 (s, 3H, SO2C6H4-4-CH3), 3.68
(ddd, 2.7, 11.2, 13.2 Hz, 1H, H2NCHPhCHPhNTs), 3.75 (ddd, 2.7,
11.2, 13.2, 1H, H2NCHPhCHPhNTs), 4.54 (d, 11.2 Hz, 1H,
H2NCHPhCHPhNTs), 4.79 (d, 11.2 Hz, 1H, H2NCHPhCHPhNTs),
6.54ꢀ7.40 (m, 28 H).
added to 5 mL of a 0.03 M MeCN solution of 1. The resulting
yellow solution was allowed to stir for 5 min before removing the
solvent under reduced pressure. The resulting yellow solid was recrys-
tallized from CH2Cl2 solution by the addition of hexane to afford a deep
yellow solid. The resulting solid is air sensitive and will degrade upon
exposure to water. Slow diffusion of a CH2Cl2 solution of the solid
into hexane resulted in light yellow crystals suitable for crystallographic
Cp*IrH(TsDPEN) Isomers. Under an atmosphere of Ar, 0.5 g
(0.72 mmol) of 1 was treated with 68 mg (1.8 mmol) of NaBH4 in 5 mL
of MeOH. After 2 min, solvent was removed from the yellow mixture
under reduced pressure. The remaining residue was extracted into 3 ꢁ
10 mL of CH2Cl2. The combined extracts concentrated under reduced
pressure to afford a yellow solid. Yield: 330 mg (66%). 1H NMR
(500 MHz, CD2Cl2): δ ꢀ11.49 (s, 1H, IrꢀH, β), ꢀ10.12 (s, 1H, IrꢀH,
R), 1.63 (s, 15H, Cp*, β), 1.89 (s, 15H, Cp*, R), 2.28 (s, 3H, SO2C6H4-
4-CH3, β), 2.35 (s, 3H, SO2C6H4-4-CH3, R), 3.36 (d, 11 Hz, 1H,
HHNCHPhCHPhNTs, β), 3.58 (d, 10.2 Hz, 1H, HHNCHPhCH-
PhNTs, R), 3.69 (ddd, 3.2, 9.6, 12.6 Hz, 1H, H2NCHPhCHPhNTs, R),
3.77 (d, 4.7 Hz, 1H, H2NCHPhCHPhNTs, β), 4.10 (t, 11.5 Hz, 1H,
HHNCHPhCHPhNTs, R), 4.16 (d, 9.6 Hz, 1H, H2NCHPhCHPhNTs, R),
4.71 (s, 1H, H2NCHPhCHPhNTs, β), 4.73 (br s, 1H, HHNC-
HPhCHPhNTs, β), 6.80ꢀ7.75 (m, 28H). 1H NMR (500 MHz,
CD3CN): δ ꢀ11.75 (s, 1H, IrꢀH, β), ꢀ10.74 (s, 1H, IrꢀH, R), 1.64
(s, 15H, Cp*, β), 1.87 (d, 0.8 Hz, 15H, Cp*, R), 2.28 (s, 3H, SO2C6H4-4-
CH3, β), 2.38 (s, 3H, SO2C6H4-4-CH3, R), 3.68 (ddd, 3.6, 9.2, 12.1 Hz,
1H, H2NCHPhCHPhNTs, R), 3.73 (m, 1H, H2NCHPhCHPhNTs, β),
3.91 (d, 11.1 Hz, 1H, HHNCHPhCHPhNTs, β), 4.15 (d, 9.2 Hz, 1H,
H2NCHPhCHPhNTs, R), 4.24 (t, 11.2 Hz, 1H, HHNCHPhCHPh-
NTs, R), 4.40 (d, 10.6 Hz, 1H, HHNCHPhCHPhNTs, R), 4.57 (s, 1H,
H2NCHPhCHPhNTs, β), 4.91 (d, 8.7 Hz, 1H, HHNCHPhCHPhNTs, β),
6.85ꢀ7.74 (m, 28H).
1
analysis. Yield: 78 mg (71%). H NMR (500 MHz, CD2Cl2): δ 1.76
(s, 15H, Cp*, β), 1.81 (s, 15H, Cp*, R), 2.19 (s, 3H, β), 2.23 (s, 3H, R),
2.35 (s, 3H, β), 2.73 (d, 0.9 Hz, 3H, β), 3.22 (br d, 1H,
HHNCHPhCHPhNTs, β), 3.60 (m, 2H, H2NCHPhCHPhNTs, R þ
β), 4.06 (br d, 1H, HHNCHPhCHPhNTs, R), 4.20 (d, 11.1 Hz, 1H,
H2NCHPhCHPhNTs, R), 4.26 (d, 10.8 Hz, 1H, H2NCHPhCHPhNTs,
β), 6.53ꢀ7.33 (m, 28H, phenyl), 8.02 (br s, 1H, HHNCHPhCHPhNTs,
R), 7.48 (br t, 1H, HHNCHPhCHPhNTs, R), 7.84 (s, 1H, SC
(NH)Me, β), 8.06 (s, 1H, SC(NH)Me, R), 11.30 (br t, 1H,
HHNCHPhCHPhNTs, β). The 1H NMR spectrum was invariant from
ꢀ30 to 40 °C. Anal. Calcd for C33H40IrN3O2S2 CH2Cl2: C, 47.93; H,
3
4.96; N, 4.93. Found: C, 47.66; H, 4.83; N, 4.87.
Cp*Ir(NO2)(TsDPEN), 1H(NO2). Nitric oxide was bubbled
through a solution of 120 mg (0.18 mmol) of 1 in 10 mL of MeCN.
An immediate color change from pale orange to brown was observed. A
tan solid was obtained upon recrystallization from CH2Cl2/hexane.
1H(NO2) can also be prepared from a CD3CN solution of 1H(Cl) and
NaNO2. Nitric oxide was purified by passage through a saturated
1
aqueous NaOH solution. Yield: 75 mg (56%). H NMR (500 MHz,
CD3CN): δ 1.78 (s, 15H, Cp*), 2.25 (s, 3H, SO2C6H4-4-Me), 3.72
(ddd, 1 H, H2NCHPhCHPhNTs), 4.23 (d, 1H, H2NCHPhCHPhNTs),
5.18 (br d, 1H, HHNCHPhCHPhNTs), 6.65 (br t, 1H, HHNCHPh-
CHPhNTs), 6.70ꢀ7.23 (m, 14H). Anal. Calcd for C31H36IrN3O4S: C,
50.39; H, 4.91; N, 5.69. Found: C, 50.07; H, 5.09; N, 5.43. FD-MS:
m/z = 693 (MHþ). The Cp* system tended to form long needles that
did not diffract well. The related (C5Me4H)Ir(NO2)(TsDPEN) was
prepared as described above (55% yield) and readily crystallized as the
CH2Cl2 solvate. 1H NMR (500 MHz, CD3CN): δ 1.76 (s, 3H,
C5Me4H), 1.80 (s, 3H, C5Me4H), 1.83 (s, 3H, C5Me4H), 1.91 (s, 3H,
C5Me4H), 2.25 (s, 3H, SO2C6H4-4-Me), 3.84 (ddd, 3.3, 11, 12.7 Hz, 1 H,
H2NCHPhCHPhNTs), 4.36 (d, 11 Hz, 1H, H2NCHPhCHPhNTs),
4.84 (br d, 7 Hz, 1H, HHNCHPhCHPhNTs), 6.47 (br t, 10 Hz, 1H,
HHNCHPhCHPhNTs), 6.70ꢀ7.23 (m, 14H).
(p-Cymene)RuH(R,R-TsDPEN) Isomers. The preparation fol-
lowed the procedure for R- and β-1H(H) (preceding procedure) starting
with 100 mg (0.17 mmol) of (p-cymene)Ru(R,R-TsDPEN-H) to afford a
mixture of (p-cymene)RuH(R,R-TsDPEN) R and β isomers as a brown
1
solid. Yield: 28 mg (28%). H NMR (500 MHz, CD2Cl2): δ ꢀ6.13
(s, 1H, RuꢀH, β), ꢀ5.82 (s, 1H, RuꢀH, R), 1.27 (d, 6.6 Hz, 3H,
CH(CH3)2, β), 1.29 (d, 6.9 Hz, 3H, CH(CH3)2, R), 1.29 (d, 6.9 Hz, 3H,
CH(CH3)2, β), 1.34 (d, 6.9 Hz, 3H, CH(CH3)2, R), 1.95 (s, 3H, CH3
cymene, β), 2.30 (s, 3H, SO2C6H4-4-CH3, β), 2.33 (s, 3H, CH3 cymene,
R), 2.37 (s, 3H, SO2C6H4-4-CH3, R), 2.61 (m, 1H, CH(CH3)2, β), 2.71
(m, 1H, CH(CH3)2, R), 3.22 (t, 12.1 Hz, 1H, HHNCHPhCHPhNTs,
R), 3.31 (m, 1H, HHNCHPhCHPhNTs, β), 3.51ꢀ3.60 (m, 2H, HHN-
CHPhCHPhNTs, R þ β), 3.72 (m, 1H, H2NCHPhCHPhNTs, β), 3.81
(d, 9.8 Hz, 1H, H2NCHPhCHPhNTs, R), 4.06 (ddd, 3.1, 9.9, 12.9 Hz, 1H,
H2NCHPhCHPhNTs, R), 4.37 (dd, 1.0, 5.8 Hz, 1H, C6H4 cymene, β),
4.73 (d, 3.6 Hz, 1H, H2NCHPhCHPhNTs, β), 4.82 (dd, 0.8, 5.8 Hz, 1H,
C6H4 cymene, R), 4.86 (d, 5.7 Hz, 1H, C6H4 cymene, β), 5.00 (dd, 1.0,
5.7 Hz, 1H, C6H4 cymene, R), 5.26 (d, 5.7 Hz, 1H, C6H4 cymene, β),
5.34 (d, 5.7 Hz, 1H, C6H4 cymene, R), 5.41ꢀ5.44 (m, 2H, C6H4 cymene,
R þ β), 6.75ꢀ7.48 (m, 28H).
Cp*Ir(2-pyridonate)(TsDPEN), 1H(2-pyridonate). A solution
of 0.14 g (0.21 mmol) of 1 in 10 mL of MeCN was treated with 5 mL of
0.041 M (0.21 mmol) MeCN solution of 2-hydroxypyridine. The
addition resulted in an instantaneous color change from reddish-purple
to yellow-orange. The solution was stirred for 5 min, and the solvent was
removed under reduced pressure. The yellow solid was recrystallized by
dissolution in 2 mL of MeCN followed by the addition of 30 mL of Et2O.
Yield: 73.3 mg (44%). 1H NMR (500 MHz, CD3CN): δ 1.61 (s, 15H,
Cp*), 1.63 (s, 15H, Cp*), 2.16 (s, 3H, SO2C6H4-4-CH3), 2.21 (s, 3H,
SO2C6H4-4-CH3), 3.57 (dt, 6.0, 11.3 Hz, 1 H, H2NCHPhCHPhNTs),
3.73 (ddd, 4.6, 10.9, 15.9 Hz, 1 H, H2NCHPhCHPhNTs), 3.79 (d, 11 Hz,
1H, H2NCHPhCHPhNTs), 3.98 (br t, 9.7 Hz, 1H, HHNCHPhCHPh-
NTs), 4.36 (d, 11 Hz, 1H, H2NCHPhCHPhNTs), 4.68 (br dd, 5.0,
10.9 Hz, 1H, HHNCHPhCHPhNTs), 6.10ꢀ6.15 (m, 2H, pyridone
ring), 6.20 (dd, 1.3, 8.6 Hz, 1H, pyridone ring), 6.35 (dt, 1.5, 6.5 Hz, 1H,
pyridone ring), 6.37ꢀ6.56 (m, 9 H), 6.58 (tt, 1.3, 7.2 Hz, 1H, pyridone
ring), 6.66 (m, 1H), 6.68 (d, 7.8 Hz, 1H, SO2C6H4-4-Me), 6.80 (d,
8.4 Hz, 1H, SO2C6H4-4-Me), 6.69ꢀ7.25 (m, 18H), 7.26 (ddd, 2.2, 6.6,
8.7 Hz, 1H, pyridone ring), 7.32 (ddd, 2.2, 6.6, 8.7 Hz, 1H, pyridone
ring), 8.52 (dd, 2.2, 6.1 Hz, 1H, pyridone ring), 8.76 (dd, 2.0, 6.1 Hz, 1H,
pyridone ring), 9.79 (br t, 7.8 Hz, 1H, HHNCHPhCHPhNTs), 11.51
(br t, 11.1 Hz, 1H, HHNCHPhCHPhNTs). 13C NMR (500 MHz,
CD3CN): δ 9.29, 9.67, 68.92, 72.03, 72.99, 73.88, 87.12, 87.43, 108.52,
108.96, 117.78, 118.20, 127.21, 127.22, 127.44, 127.66, 127.99, 128.01,
Cp*Ir(NH(CO)Me)(TsDPEN), 1H(NH(CO)Me). A MeCN solu-
tion of acetamide (1.2 mL, 0.14 M) was added to a flask containing 100
mg (0.14 mmol) of solid 1. The purple solution was allowed to stir
overnight, affording a yellow precipitate. The precipitate was filtered off and
washed with hexane. Yield: 50 mg (46%). 1H NMR (500 MHz, CD3CN): δ
1.73 (s, 15H, Cp*), 1.98 (s, 3H, H3CCONHIr), 2.18 (s, 3H, SO2C6H4-4-
CH3), 3.61 (ddd, 3.4, 11.4, 12.5 Hz, 1H, H2NCHPhCHPhNTs), 4.17 (br d,
1H, HHNCHPhCHPhNTs), 4.26 (d, 11.2 Hz, 1H, H2NCHPhCHPhNTs),
5.12 (br s, 1H, H3CCONHIr), 6.59ꢀ7.62 (m, 14H), 11.24 (br t, 11 Hz, 1H,
HHNCHPhCHPhNTs). Upon dissolving the sample in CD3CN, the yellow
solution turned purple concomitant with the appearance of signals for 1 in the
1H NMR spectrum.
Cp*Ir(SC(NH)Me)(TsDPEN), 1H(SC(NH)Me). Under an atmo-
sphere of Ar, 1.6 mL of a 0.09 M MeCN solution of thioacetamide was
5564
dx.doi.org/10.1021/ic200160q |Inorg. Chem. 2011, 50, 5558–5566